Acute Reversible Motor Predominant Polyradiculoneuropathy among Thai Prisoners after the Outbreak of H3N2 Influenza: A Case Series
Abstract
Objective: This study aims to describe the clinical, laboratory and electrophysiological findings of the prisoners who developed acute reversible motor predominant polyradiculoneuropathy after the outbreak of H3N2 influenza.
Material and Methods: Among H3N2 infected Thai prisoners, all patients with acute flaccid weakness were included in this retrospective case series. We analyzed the results of electromyography (EMG), cerebrospinal fluid analysis, and serum levels of antiganglioside antibodies, folate, thiamine, and vitamin B12.
Results: Among 262 H3N2 influenza patients, motor predominant polyradiculoneuropathy predominantly affecting the lower limbs developed in 10 patients. EMG revealed significantly decreased compound muscle action potentials with preserved distal latencies and conduction velocities in the peroneal nerves. Early fibrillation potentials were demonstrated on EMG performed 12-14 days post-onset of symptoms. The cerebrospinal fluid study showed normal profiles. All laboratory results appeared normal except for the significantly low mean±standard deviation serum folate level of 1.80± 0.78 [reference value 3.89–26.80 nanograms per milliliter (ng/mL)] as compared to the mean serum folate level in the normal Thai population of 10.80 ng/mL (p-value<0.001, 95% confidential interval -9.55 to -8.45). All patients were treated with 15 milligram per day of folic acid and all patients improved clinically.
Conclusion: Although the relationship between low plasma folate level and polyradiculoneuropathy is unclear, a superimposed folate deficiency contributing to the pathophysiology is possible.
Keywords
Full Text:
PDFReferences
Marx A, Glass JD, Sutter RW. Differential diagnosis of acute flaccid paralysis and its role in poliomyelitis surveillance. Epidemiol Rev 2000;22:298-316.
Areekul S, Cheeramakara C, Churdchu K, Pongpaew P, Suwanbun N. Serum folate and vitamin B12 levels in chronic alcoholics. Siriraj Hosp Gaz 1993;45:14-8.
Zeng Y, Liu Y, Xie Y, Liang J, Xiao Z, Lu Z. Clinical Features and the validation of the brighton criteria in Guillain-Barré syndrome: retrospective analysis of 72 hospitalized patients in three years. Eur Neurol 2019;1:1-8.
Willison HJ, Goodyear CS. Glycolipid antigens and autoantibodies in autoimmune neuropathies. Trends Immunol 2013;34:453–9.
Jacobs BC, Rothbarth PH, van der Meché FG, Herbrink P, Schmitz PI, de Klerk MA, et al. The spectrum of antecedent infections in Guillain-Barré syndrome: a case-control study. Neurology 1998;51:1110–5.
Paploski IA, Prates AP, Cardoso CW, Kikuti M, Silva MM, Waller LA, et al. Time lags between exanthematous illness attributed to Zika Virus, Guillain-Barré syndrome, and microcephaly, Salvador, Brazil. Emerg Infect Dis 2016;22:1438- 44.
Kwong JC, Vasa PP, Campitelli MA, Hawken S, Wilson K, Rosella LC, et al. Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis 2013; 13:769-76.
Dumitru D, King JC. Fibrillation potential amplitude after denervation. Am J Phys Med Rehabil 1998;77:483-9.
Koike H, Takahashi M, Ohyama K, Hashimoto R, Kawagashira Y, Iijima M, et al. Clinicopathologic features of folate-deficiency neuropathy. Neurology 2015;84:1026-33.
Botez MI, Peyronnard JM, Bachevalier J, Charron L. Polyneuropathy and folate deficiency. Arch Neurol 1978;35:581-4.
Koike H, Hama T, Kawagashira Y, Hashimoto R, Tomita M, Iijima M, et al. The significance of folate deficiency in alcoholic and nutritional neuropathies: analysis of a case. Nutrition 2012;28:821-4.
Kreijtz JH, Fouchier RA, Rimmelzwaan GF. Immune responses to influenza virus infection.Virus Res 2011;162:19-30.
Xia W, Hilgenbrink AR, Matteson EL, Lockwood MB, Cheng JX, Low PS. A functional folate receptor is induced during macrophage activation and can be used to target drugs to activated macrophages. Blood 2009;113:438-46.
Yi YS. Folate receptor-targeted diagnostics and therapeutics for inflammatory diseases. Immune Netw 2016;16:337- 43.
Osifo BO, Lukanmbi FA, Familusi JB. Increase of body temperature and folic acid metabolism. Acta Vitaminol Enzymol 1981;3:177-81.
Refbacks
- There are currently no refbacks.
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.